Krishna Pillai Selected Research

Expectorants (Mucolytics)

1/2022	A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
6/2017	Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study.
1/2014	Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters.
10/2012	Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei.
5/2012	Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krishna Pillai Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2011
7	Pseudomyxoma Peritonei 08/2021 - 05/2012
4	Mesothelioma 02/2014 - 10/2012
3	Neoplasm Metastasis (Metastasis) 02/2015 - 10/2012
3	Ascites 01/2014 - 05/2012
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 05/2013 - 01/2013
2	Malignant Mesothelioma 10/2012 - 01/2011
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	COVID-19 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Rare Diseases (Rare Disease) 01/2017
1	Carcinogenesis 01/2017
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 02/2013
1	Carcinoma (Carcinomatosis) 01/2013

Drug/Important Bio-Agent (IBA)

5	Expectorants (Mucolytics)IBA 01/2022 - 05/2012
5	Bromelains (Bromelain)IBA 01/2020 - 01/2013
5	MucinsIBA 01/2017 - 05/2012
4	bromelain and acetylcysteine drug combinationIBA 01/2022 - 01/2021
3	Gemcitabine FDA Link 01/2021 - 01/2018
3	Glycoproteins (Glycoprotein)IBA 01/2017 - 05/2013
3	Albendazole (Albenza)FDA Link 01/2017 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 02/2015 - 05/2013
3	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 10/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 02/2014
2	AsbestosIBA 02/2014 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2013 - 01/2013
1	Drug CombinationsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2020
1	1-dodecylpyridoxal (PLD)IBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	monepantelIBA 01/2018
1	SolutionsIBA 06/2017
1	Biological ProductsIBA 01/2017
1	CyclodextrinsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	Cysteine (L-Cysteine)FDA Link 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2013
1	2-MethoxyestradiolIBA 02/2013
1	Colchicine FDA LinkGeneric 02/2013
1	AnthelminticsIBA 02/2013
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2013
1	CaspasesIBA 01/2013
1	lissamine rhodamine B (sulforhodamine B)IBA 01/2013
1	raltitrexed (D 1694)IBA 10/2012
1	PlatinumIBA 10/2012
1	Folic Acid AntagonistsIBA 10/2012
1	Pemetrexed (MTA)FDA Link 10/2012
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2012
1	Estrogen ReceptorsIBA 01/2011

Therapy/Procedure

4	Therapeutics 01/2018 - 02/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2012
2	Radiofrequency Ablation 06/2015 - 06/2014
2	Cytoreduction Surgical Procedures 10/2012 - 01/2011
1	Intranasal Administration 01/2021
1	Intraperitoneal Injections 01/2021
1	Catheters 01/2014
1	Combination Drug Therapy (Combination Chemotherapy) 10/2012
1	Hyperthermic Intraperitoneal Chemotherapy 01/2011